Themenplan Ausgabe 5/25
Experimental and Clinical Endocrinology & Diabetes
Termine
| Termine | Datum |
|---|---|
| Erscheinungstermin | 21.05.2025 |
| Anzeigenschluss | 10.04.2025 |
| Druckunterlagenschluss | 23.04.2025 |
| Liefertermin | 05.05.2025 |
Themenübersicht
| Rubrik | Beitrag | |||||
|---|---|---|---|---|---|---|
| Article | Incidence, Temporal Trends, and Socioeconomic Aspects of Acquired Male Hypogonadism | |||||
| Article | Roles of Transmembrane Protein 119 in the Effects of Transforming Growth Factor-β on Mouse Bone Cells | |||||
| Article | Association of FGF21 with Metabolic and Cardiovascular Diseases: A Mendelian Randomization Analysis | |||||
| Article | Efficacy of Propranolol Combined with Different Modalities of Unilateral Adrenalectomy in a Case Series of 4 ARMC5-mutated Patients | |||||
| Article | Anti-Inflammatory and Survival Benefits of Dipeptidyl Peptidase 4 Inhibitors Among Patients with Gout, T2DM Patients and Chronic Kidney Disease | |||||
| Mini-Review | Contraception and Diabetes Mellitus | |||||
| Änderungen bei den Themenplanungen behält sich die Redaktion vor. | ||||||
ISSN
0947-7349Erscheinungsweise
12-mal jährlichDruckauflage
1.600 ExemplareImpact-Factor
1.7Ihre Ansprechpartnerin zum Themenplan
Eleonore Warlitz
- +49 711 8931 304
- Eleonore.Warlitz@thieme-media.de